Jeuveau – The Newest Neurotoxin
Jeuveau is the first product of its kind – an injectable treatment that temporarily improves frown lines. On February 1, 2019, the FDA approved the latest cutting-edge injectable containing Botulinum Toxin A— Jeuveau by Evolus.
What Is Jeuveau Injectable?
How Does Jeuveau Work?
Jeuveau Treatment Areas
Jeuveau Treatment Results
Jeuveau VS Botox
Botox has been in the market since the 90’s, we have been successfully treating patients with Botox for many years. Jeuveau is the first new Botox alternative in a decade. As the fourth neurotoxin to hit the market, Jeuveau is made using a state-of-the-art manufacturing process called Hi-Pure™ technology. Jeuveau is the first product from Evolus, and part of its mission to bring a fresh experience and perspective to the aesthetics industry.
See full prescribing information here: JEUVEAU CONSUMER Important Safety Information